Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NMRANMRA
Showing 8 of 11 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in NEUMORA THERAPEUTICS INC.

Yes. Charles Schwab Investment Management holds 823,583 shares of NMRA (Neumora Therapeutics), worth $1.4M, as of its Q2 2026 13F filing. It increased the position by 307,401 shares (+59.6%) from Q1 2026. Charles Schwab Investment Management has held NMRA since Q4 2023, across 11 quarterly 13F filings.

Current Value

$1.4M

Current Shares

823,583

Total Value Change

-$7.8M

Total Shares Change

+125,328

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
823,583
+59.5%
$1.4M0.0%$1.70
37
2026-Q1
Increased
516,182
+0.7%
$1M0.0%$3.06
25
2025-Q4
Decreased
512,470
-0.1%
$917,3210.0%$1.77
0
2025-Q3
Increased
512,939
+15.7%
$933,5490.0%$1.76
29
2025-Q2
Decreased
443,167
-25.3%
$324,9740.0%$0.76
0
2025-Q1
Decreased
593,498
-15.7%
$593,4980.0%$1.03
0
2024-Q4
Increased
704,154
+0.8%
$7.5M0.0%$11.06
28
2024-Q3
Increased
698,255
+139.7%
$9.2M0.0%$12.92
45

Other major holders of NMRA: SOFTBANK GROUP CORP., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used